In previously irradiated patients, the therapeutic window is often narrow, and there may be significant risks associated with the high cumulative radiation dose to normal tissues, which can be mitigated through improved sparing of these normal non-target tissues.
← all excerpts
A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors.
1
—
—